FDA approves Roivant therapy for rare autoimmune disease
FDA approves Roivant therapy for rare autoimmune disease STAT
Finance, IT & News
FDA approves Roivant therapy for rare autoimmune disease STAT
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis)…
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
Gorilla Technology is investing billions in AI projects as Fitch Ratings gives it a B- rating Stock Titan
S&P Affirms India's 'BBB' Rating: Dynamic Economy, Stable Outlook Rediff MoneyWiz